title: Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.
abstract: Infections with the opportunistic yeast Candida glabrata have increased dramatically in recent years. Antifungal therapy of yeast infections commonly employs azoles, such as fluconazole (FLC), but C. glabrata frequently develops resistance to these inhibitors of ergosterol biosynthesis. The pyrimidine analog flucytosine (5-fluorocytosine [5FC]) is highly active versus C. glabrata but is now rarely used clinically due to similar concerns over resistance and, a related concern, the toxicity associated with high doses used to counter resistance. Azole-5FC combination therapy would potentially address these concerns; however, previous studies suggest that 5FC may antagonize azole activity versus C. glabrata. Here, we report that 5FC at subinhibitory concentrations antagonized the activity of FLC 4- to 16-fold versus 8 of 8 C. glabrata isolates tested. 5FC antagonized the activity of other azoles similarly but had only indifferent effects in combination with unrelated antifungals. Since azole resistance in C. glabrata results from transcription factor Pdr1-dependent upregulation of the multidrug transporter gene CDR1, we reasoned that 5FC antagonism might be similarly mediated. Indeed, 5FC-FLC antagonism was abrogated in pdr1Δ and cdr1Δ strains. In further support of this hypothesis, 5FC exposure induced CDR1 expression 6-fold, and this upregulation was Pdr1 dependent. In contrast to azoles, 5FC is not a Cdr1 substrate and so its activation of Pdr1 was unexpected. We observed, however, that 5FC exposure readily induced petite mutants, which exhibit Pdr1-dependent CDR1 upregulation. Thus, mitochondrial dysfunction resulting in Pdr1 activation is the likely basis for 5FC antagonism of azole activity versus C. glabrata.
authors: Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
authors: Zoë
authors: Z
authors: Steier
authors: John-Paul
authors: JP
authors: Vermitsky
authors: Geoffrey
authors: G
authors: Toner
authors: Scott E
authors: SE
authors: Gygax
authors: Thomas
authors: T
authors: Edlind
authors: Santosh
authors: S
authors: Katiyar
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000172:deficiency / Q000235:genetics*; D000935:Antifungal Agents / Q000494:pharmacology; D041221:Candida glabrata / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D004336:Drug Antagonism; D025141:Drug Resistance, Fungal / Q000187:drug effects / Q000235:genetics*; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000494:pharmacology; D005437:Flucytosine / Q000494:pharmacology; D005656:Fungal Proteins / Q000235:genetics* / Q000378:metabolism; D015966:Gene Expression Regulation, Fungal; D008928:Mitochondria / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D014157:Transcription Factors / Q000172:deficiency / Q000235:genetics*
chemical_list: D018528:ATP-Binding Cassette Transporters; D000935:Antifungal Agents; D005656:Fungal Proteins; D014157:Transcription Factors; D015725:Fluconazole; D005437:Flucytosine
references: Antimicrob Agents Chemother. 2001 Apr;45(4):1174-83
references: 11257032
references: Clin Infect Dis. 2009 Mar 1;48(5):503-35
references: 19191635
references: Curr Genet. 2005 Aug;48(2):117-25
references: 16078083
references: J Antimicrob Chemother. 1998 Mar;41(3):357-66
references: 9578162
references: Clin Microbiol Rev. 2007 Jan;20(1):133-63
references: 17223626
references: Antimicrob Agents Chemother. 2004 May;48(5):1600-13
references: 15105111
references: Mol Cell Biol. 2002 Dec;22(24):8774-86
references: 12446794
references: Mol Microbiol. 2006 Aug;61(3):704-22
references: 16803598
references: Antimicrob Agents Chemother. 2010 Nov;54(11):4733-8
references: 20823283
references: Mycopathologia. 2012 Sep;174(3):215-21
references: 22528740
references: PLoS Pathog. 2010 Sep 30;6(9):e1001126
references: 20941354
references: Antimicrob Agents Chemother. 1999 Aug;43(8):1968-74
references: 10428921
references: J Antimicrob Chemother. 2000 Aug;46(2):171-9
references: 10933638
references: Antimicrob Agents Chemother. 2004 May;48(5):1788-96
references: 15105136
references: Antimicrob Agents Chemother. 2002 Sep;46(9):2982-9
references: 12183257
references: Antimicrob Agents Chemother. 2008 Sep;52(9):3424-6
references: 18591262
references: Antimicrob Agents Chemother. 2004 Mar;48(3):693-715
references: 14982754
references: Mol Gen Genet. 1976 Aug 2;146(3):253-9
references: 794690
references: J Biol Chem. 2000 Dec 1;275(48):37347-56
references: 10980204
references: Antimicrob Agents Chemother. 2004 Sep;48(9):3317-22
references: 15328091
references: Antimicrob Agents Chemother. 2004 Oct;48(10):3773-81
references: 15388433
references: Antimicrob Agents Chemother. 2006 Apr;50(4):1384-92
references: 16569856
references: Clin Infect Dis. 2004 Aug 1;39(3):309-17
references: 15306996
references: PLoS Pathog. 2009 Jan;5(1):e1000268
references: 19148266
references: Mutagenesis. 2002 Sep;17(5):375-81
references: 12202624
references: Clin Microbiol Infect. 2004 Mar;10 Suppl 1:11-23
references: 14748799
references: Antimicrob Agents Chemother. 2002 Nov;46(11):3518-21
references: 12384359